Zydus launches REVAHALE, India’s first once-daily nebulised LAMA for COPD
REVAHALE (Revefenacin) offers sustained 24-hour bronchodilation through convenient nebulised delivery
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Emcure to expand use of Poviztra for MASH indication after CDSCO nod
Poviztra® is manufactured and imported from Novo Nordisk's European manufacturing facility and contains innovator rDNA-origin…
Viatris launches support project in Maharashtra to combat DR-TB
The project aims to strengthen tuberculosis care through diagnostics, prevention and nutrition in Nagpur
Takeda gets DCGI approval for its dengue vaccine QDENGA (TAK-003)
QDENGA, now approved in 43 countries, including India, is designed to protect against all four dengue virus serotypes
Alembic Pharma announces partner NATCO Pharma gets USFDA tentative nod for Olaparib tablets
Alembic will distribute the product in the US, and its partner NATCO will manufacture Olaparib Tablets, 100 mg and 150 mg
Leiutis marks global milestone with CDSCO approval for Synthetic Cannabidiol Oral Solution for mild…
Leiutis Pharmaceuticals LLP has announced that the Central Drugs Standard Control Organisation (CDSCO) has granted regulatory…
Alembic Pharmaceuticals gets USFDA approval for Dapsone Gel, 5%
Dapsone Gel is indicated for the topical treatment of acne vulgaris
Strides partners with Ascent Capital to unlock value in Pivot Path
Deal values Pivot Path at ~₹2.3 billion post-money; Strides to realise ~₹1 billion while retaining around 20 per cent stake.
Alembic gets USFDA nod for Oseltamivir Phosphate for Oral Suspension
Oseltamivir Phosphate is an influenza neuraminidase inhibitor (NAI) indicated for treatment of acute, uncomplicated…
Zydus Lifesciences, Sunshine Healthcare sign JV to set up pharma facility in Sri Lanka
The facility, to be located at the Board of Investment zone in Horana, will be developed on nearly four acres of land, an an…
Indoco Remedies Goa Plant successfully clears Malta Medicines Authority audit
The facility has received EU GMP certification from the Malta Medicines Authority
Lupin gets tentative nod from US FDA for Enzalutamide tablets
The tentative approval covers the 40 mg, 80 mg, 120 mg, and 160 mg strengths
Shilpa Biologicals commissions ADC GMP manufacturing facility in Dharwad
The company informed that the facility which is fully operational, is designed to meet global regulatory approval standards
Lilly launches Tanstrive (Selpercatinib), a RET inhibitor to treat advanced cancers with RET gene…
Available in India in 40 mg, 80 mg, 120 mg and 160 mg tablet strengths; administered orally twice daily
Concord Biotech clears Kenya, Uganda regulatory inspection
The inspection was conducted from June 18 to June 24, 2026
Pharma deal value rises 156.8% in May 2026: GlobalData
Healthcare sector records 68 deals worth $18.5 billion, while venture capital funding declines 21.5 per cent year-on-year
Indoco Remedies clears Malta Medicines Authority audit
The facility has received EU GMP certification from the Malta Medicines Authority confirming that it complies with the Good…
Zydus to acquire Assertio in all-cash tender offer
Assertio is focused on specialty and oncology supportive-care therapies
Lupin gets US FDA nod for Famotidine Injection, USP
This product would be manufactured at Lupin’s Nagpur facility in India
Healthcare deal value rises 340 per cent in April 2026: GlobalData
Sun Pharma-Organon, Eli Lilly-Kelonia and Gilead-Tubulis among the major deals reported during the month